Stock AKBA AKEBIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
1.27 USD +17.59% Intraday chart for Akebia Therapeutics, Inc. +34.18% +2.42%
Jul. 11 Sector Update: Health Care Stocks Advance Premarket Thursday MT
Jul. 11 Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AKEBIA THERAPEUTICS, INC. Stock Akebia Therapeutics, Inc.
 266M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 117B
ARGENX SE Stock argenx SE
 27.77B -
BIONTECH SE Stock BioNTech SE
 20.44B -
GENMAB A/S Stock Genmab A/S
 16.62B
  1. Stock Market
  2. Equities
  3. AKBA Stock
  4. Charts Akebia Therapeutics, Inc.
  5. Sector Chart